您的账号已在其他设备登录,您当前账号已强迫下线,
如非您本人操作,建议您在会员中心进行密码修改

确定
收藏 | 浏览34

World Health Organization in its treatment guideline for tuberculosis 2010 recommended daily dosing as the preferred regimen in treatment of drug-sensitive TB patients. The Revised National Tuberculosis Control Program took a decision to implement daily regimen in five states of India in 2015. This article describes the policy-making chronology, evidences used, stakeholders involved, and process of decision making.

作者:K S, Sachdeva;A, Shah;K, Rade;R, Ramachandran;A, Sreenivas;M, Parmar;M, Ghedia;V S, Salhotra;S D, Khaprde;J, Prasad

来源:The Indian journal of tuberculosis 2015 年 62卷 4期

知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求,方便快速、便捷的获取实用的医学信息,辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍
热门关注
免责声明:本知识库提供的有关内容等信息仅供学习参考,不代替医生的诊断和医嘱。

收藏
| 浏览:34
作者:
K S, Sachdeva;A, Shah;K, Rade;R, Ramachandran;A, Sreenivas;M, Parmar;M, Ghedia;V S, Salhotra;S D, Khaprde;J, Prasad
来源:
The Indian journal of tuberculosis 2015 年 62卷 4期
标签:
Daily Anti-TB Regimen Drug sensitive Tuberculosis India Revised National Tuberculosis Control Program Tuberculosis
World Health Organization in its treatment guideline for tuberculosis 2010 recommended daily dosing as the preferred regimen in treatment of drug-sensitive TB patients. The Revised National Tuberculosis Control Program took a decision to implement daily regimen in five states of India in 2015. This article describes the policy-making chronology, evidences used, stakeholders involved, and process of decision making.